BioSpace: Biotech, Pharmaceutical and Clinical Research News
Dec 11, 2010 · The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few months later.
News - BioSpace
Biopharma executives shared their thoughts on the potential impacts of the new administration; Annalee Armstrong recaps JPM and her talks with Biogen, Gilead, Novavax and more; …
Parabilis Medicines™ – Formerly FogPharma - BioSpace
Oct 28, 2024 · BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals …
Regeneron Acquisition of Oxular Wipes Out Oxular Workforce
Jan 3, 2025 · 2024 was a tough year for the biopharma industry, with several companies including Bayer, Bristol Myers Squibb and Johnson & Johnson are cutting hundreds or even thousands …
Camurus announces FDA approval of Brixadi™ for the ... - BioSpace
Camurus announces that the US Food and Drug Administration has approved Brixadi™ extended release injection for subcutaneous use, a weekly and monthly medication for the treatment of …
Genencor International, Inc. Launches Revolutionary Enzyme
PALO ALTO, Calif., March 27 /PRNewswire/ -- Genencor International, Inc. announced today a European Notified Body has assessed and certified the first enzyme technology designed …
BioSpace - BioSpace
Jul 31, 2024 · BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals …
ESSENCE Phase 3 trial results demonstrating statistically
The trial achieved both its primary endpoints, with semaglutide 2.4 mg demonstrating statistically significant and superior improvements in liver fibrosis with no worsening of steatohepatitis, as …
About Us - BioSpace
BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who …
Phase III Clinical Trials - BioSpace
Jan 17, 2025 · The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which exceeded the consensus by a modest 1% …